Further to this, GLP‐1 therapy has also been shown to augment anti‐inflammatory and anti‐atherosclerotic processes, demonstrated by their ability to reduce occurrence of myocardial infarctions and strokes (Tanaka & Node, 2018). Here, GCG is linked to myocardial infarction.